COVID-19

COVID-19 and liver disease

Jean-François Dufour, Thomas Marjot, Chiara Becchetti, Herbert Tilg

10.1136/gutjnl-2021-326792

June 14, 2022

Serological responses to three doses of SARS-CoV-2 vaccination in inflammatory bowel disease

Joshua Quan, Christopher Ma, Remo Panaccione, Lindsay Hracs, Nastaran Sharifi, Michelle Herauf, Ante Makovinović, Stephanie Coward, Joseph W Windsor, Léa Caplan, Richard J M Ingram, Jamil N Kanji, Graham Tipples, Jessalyn K Holodinsky, Charles N Bernstein, Douglas J Mahoney, Sasha Bernatsky, Eric I Benchimol, Gilaad G Kaplan, the STOP COVID-19 in IBD Research Group, Lisa Barrett, Gurmeet Bindra, Carmen Charlton, Melissa Chan, Usha Chauhan, Jose Ferraz, Sharyle Fowler, Anne Griffiths, Jennifer Jones, Reena Khanna, M Ellen Kuenzig, Peter L Lakatos, Kate Lee, Cathy Lu, David Mack, John Marshall, Kerri Novak, Cynthia H Seow, Abdu Sharkawy, Tushar Shukla, Laura Targownik, LeeAnn Turnbull, Sandra Zelinsky

10.1136/gutjnl-2022-327440

May 23, 2022

Oral famotidine versus placebo in non-hospitalised patients with COVID-19: a randomised, double-blind, data-intense, phase 2 clinical trial

Christina M Brennan, Sandeep Nadella, Xiang Zhao, Richard J Dima, Nicole Jordan-Martin, Breanna R Demestichas, Sam O Kleeman, Miriam Ferrer, Eva Carlotta von Gablenz, Nicholas Mourikis, Michael E Rubin, Harsha Adnani, Hassal Lee, Taehoon Ha, Soma Prum, Cheryl B Schleicher, Sharon S Fox, Michael G Ryan, Christina Pili, Gary Goldberg, James M Crawford, Sara Goodwin, Xiaoyue Zhang, Jonathan B Preall, Ana S H Costa, Joseph Conigliaro, Joseph R Masci, Jie Yang, David A Tuveson, Kevin J Tracey, Tobias Janowitz

10.1136/gutjnl-2022-326952

February 10, 2022